Target Price | $48.96 |
Price | $44.23 |
Potential | 10.69% |
Number of Estimates | 16 |
16 Analysts have issued a price target Exelon 2026 . The average Exelon target price is $48.96. This is 10.69% higher than the current stock price. The highest price target is $54.60 23.45% , the lowest is $37.37 15.51% . | |
A rating was issued by 21 analysts: 10 Analysts recommend Exelon to buy, 9 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Exelon stock has an average upside potential 2026 of 10.69% . Most analysts recommend the Exelon stock at Purchase. |
15 Analysts have issued a sales forecast Exelon 2025 . The average Exelon sales estimate is $24.3b . This is 2.17% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $25.5b 7.25% , the lowest is $23.0b 3.43% .
This results in the following potential growth metrics:
2024 | $23.0b | 5.99% |
---|---|---|
2025 | $24.3b | 5.45% |
2026 | $25.0b | 2.90% |
2027 | $25.7b | 2.83% |
2028 | $26.8b | 4.34% |
2029 | $27.8b | 3.57% |
15 Analysts have issued an Exelon EBITDA forecast 2025. The average Exelon EBITDA estimate is $8.9b . This is 6.42% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $9.6b 14.67% , the lowest is $8.3b 0.84% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $7.9b | 5.08% |
---|---|---|
2025 | $8.9b | 12.86% |
2026 | $9.6b | 7.37% |
2027 | $10.3b | 7.40% |
2028 | $10.8b | 5.47% |
2029 | $11.5b | 5.88% |
2024 | 34.31% | 0.86% |
---|---|---|
2025 | 36.72% | 7.02% |
2026 | 38.32% | 4.36% |
2027 | 40.02% | 4.44% |
2028 | 40.45% | 1.07% |
2029 | 41.35% | 2.22% |
18 Exelon Analysts have issued a net profit forecast 2025. The average Exelon net profit estimate is $2.7b . This is 3.50% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.9b 8.33% , the lowest is $2.7b 0.01% .
This results in the following potential growth metrics and future Net Margins:
2024 | $2.5b | 5.67% |
---|---|---|
2025 | $2.7b | 11.62% |
2026 | $2.9b | 4.80% |
2027 | $3.1b | 6.49% |
2028 | $3.3b | 6.92% |
2029 | $3.5b | 7.31% |
2024 | 10.68% | 0.30% |
---|---|---|
2025 | 11.31% | 5.87% |
2026 | 11.52% | 1.86% |
2027 | 11.93% | 3.56% |
2028 | 12.22% | 2.43% |
2029 | 12.66% | 3.60% |
18 Analysts have issued a Exelon forecast for earnings per share. The average Exelon EPS is $2.72 . This is 3.42% higher than earnings per share in the financial year 2024. The highest EPS forecast is $2.85 8.37% , the lowest is $2.63 0.00% .
This results in the following potential growth metrics and future valuations:
2024 | $2.45 | 4.70% |
---|---|---|
2025 | $2.72 | 11.02% |
2026 | $2.85 | 4.78% |
2027 | $3.03 | 6.32% |
2028 | $3.24 | 6.93% |
2029 | $3.48 | 7.41% |
Current | 16.82 | 1.06% |
---|---|---|
2025 | 16.27 | 3.26% |
2026 | 15.52 | 4.61% |
2027 | 14.58 | 6.06% |
2028 | 13.63 | 6.52% |
2029 | 12.71 | 6.75% |
Based on analysts' sales estimates for 2025, the Exelon stock is valued at an EV/Sales of 3.82 and an P/S ratio of 1.84 .
This results in the following potential growth metrics and future valuations:
Current | 3.90 | 3.72% |
---|---|---|
2025 | 3.82 | 2.02% |
2026 | 3.71 | 2.82% |
2027 | 3.61 | 2.75% |
2028 | 3.46 | 4.16% |
2029 | 3.34 | 3.45% |
Current | 1.88 | 6.19% |
---|---|---|
2025 | 1.84 | 2.12% |
2026 | 1.79 | 2.82% |
2027 | 1.74 | 2.76% |
2028 | 1.67 | 4.16% |
2029 | 1.61 | 3.44% |
Analyst | Rating | Action | Date |
---|---|---|---|
Keybanc |
Underweight
➜
Underweight
|
Unchanged | Jul 16 2025 |
UBS |
Neutral
➜
Neutral
|
Unchanged | Jul 11 2025 |
UBS |
Neutral
➜
Neutral
|
Unchanged | Jun 02 2025 |
Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | May 22 2025 |
Keybanc |
Sector Weight
➜
Underweight
|
Downgrade | May 14 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | May 02 2025 |
Evercore ISI Group |
In-Line
➜
In-Line
|
Unchanged | May 02 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Keybanc:
Underweight
➜
Underweight
|
Jul 16 2025 |
Unchanged
UBS:
Neutral
➜
Neutral
|
Jul 11 2025 |
Unchanged
UBS:
Neutral
➜
Neutral
|
Jun 02 2025 |
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
May 22 2025 |
Downgrade
Keybanc:
Sector Weight
➜
Underweight
|
May 14 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
May 02 2025 |
Unchanged
Evercore ISI Group:
In-Line
➜
In-Line
|
May 02 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.